https://www.dovepress.com/pan-cancer-analysis-of-the-n6-methyladenosine-eraser-fto-as-a-potentia-peer-reviewed-fulltext-article-IJGM
Another craker.
"FTO was aberrantly expressed across cancers and survival analysis demonstrated that its expression was associated with clinical prognosis of many cancer patients. Specifically, FTO expression was significantly associated with immune infiltrating cells in colon adenocarcinoma, kidney renal clear cell carcinoma, and liver hepatocellular carcinoma. In addition, FTO expression was significantly associated with immune checkpoint genes expression, MMR, DNA methyltransferases levels, TMB, and MSI in multiple cancers. Moreover, the GSEA unveiled that FTO was involved in the regulation of tumors and immune-related signaling pathways. In addition, several m6A related genes were implicated in the PPI network of FTO."
- Forums
- ASX - By Stock
- RAC
- Pillar 1 - FTO (new thread)
Pillar 1 - FTO (new thread), page-1658
-
-
- There are more pages in this discussion • 1,367 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
-0.060(3.79%) |
Mkt cap ! $259.9M |
Open | High | Low | Value | Volume |
$1.54 | $1.56 | $1.53 | $130.2K | 84.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4993 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 10451 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4993 | 1.525 |
1 | 12381 | 1.520 |
3 | 9872 | 1.510 |
3 | 11327 | 1.505 |
9 | 14363 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 10451 | 1 |
1.595 | 6000 | 1 |
1.600 | 23239 | 1 |
1.630 | 6183 | 1 |
1.650 | 17029 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online